Artificial Intelligence (AI) in Pharmaceutical Market
Artificial Intelligence (AI) in Pharmaceutical Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Artificial Intelligence (AI) in Pharmaceutical Market Size and Growth
The Artificial Intelligence (AI) in Pharmaceutical market is experiencing rapid growth due to advancements in technology and increasing demand for personalized medicine. Market research reports project the market to reach a size of $6.6 billion by 2027. AI is revolutionizing drug discovery, clinical trials, and personalized medicine, driving innovation in the pharmaceutical industry.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ AstraZeneca LLC
◍ Atomwise Inc
◍ Bayer AG
◍ Cloud Pharmaceuticals Inc
◍ GNS Healthcare
◍ IBM Watson
◍ Merck & Co.
◍ Microsoft Corporation
◍ Novartis AG
◍ NVIDIA Corporation
◍ Pfizer Inc.
◍ Recursion Pharmaceuticals Inc.
◍ XtalPi Inc
Competitive Landscape: AstraZeneca, Bayer, Novartis, Merck, Pfizer, Microsoft, IBM, NVIDIA, Atomwise, GNS Healthcare, Cloud Pharmaceuticals, Recursion Pharmaceuticals, XtalPi.
Overview: These companies use AI for drug discovery, development, personalized medicine, clinical trials, and data analysis. They contribute to the growth of the AI in Pharmaceutical Market by increasing efficiency, productivity, and accuracy in drug development processes.
Sales Revenue:
- Novartis AG: $47.76 billion - Merck & Co.: $46.8 billion - Pfizer Inc.: $51.75 billion
Request Sample Report
Market Segmentation
By Application
Pharmaceutical Company
Institute of Biology
Others
Request Sample Report
By Product
◍
◍
◍
◍
◍
Hardware
Software
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients